ALPELISIB - Food and Drug Administration
- Manufacturer
- Food and Drug Administration
- Effective date
- 2019-08-28
- Label type
- Indexing - product concept
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-05 00:18:33
Label at a glance#
ProductALPELISIB
Active ingredientALPELISIB
Products#
Every source-derived product name is available through these pages.
- ALPELISIB
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ALPELISIB | 08W5N2C97Q | ACTIB |
| ALPELISIB | 08W5N2C97Q | ACTIB |
| ALPELISIB | 08W5N2C97Q | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PIQRAY | ALPELISIB | Novartis Pharmaceuticals Corporation | b20b4e18-7a4b-4500-a08f-06c6dab0ee5b | 2025-12-15 | Warnings, Adverse reactions | ALPELISIB |
| VIJOICE | ALPELISIB | Novartis Pharmaceuticals Corporation | 638069a4-aee0-46c9-9e21-54ad449c163c | 2025-11-04 | Warnings, Adverse reactions | ALPELISIB |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.